BioNexus Gene Lab (BGLC) Revenue (2018 - 2026)

BioNexus Gene Lab has disclosed Revenue across 9 years of filings, most recently posting $76156.0 for Q2 2026.

• In Q2 2026, Revenue fell 96.63% year-over-year to $76156.0; the TTM figure through Jun 2026 stood at $3.1 million (down 67.27% YoY), while the FY2025 annual figure was $7.4 million, down 21.93% from the prior year.
• Revenue came in at $76156.0 for Q2 2026 at BioNexus Gene Lab, up from $22842.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $3.0 million in Q1 2022 to a low of $22842.0 in Q1 2026.
• Average Revenue over 5 years is $2.1 million, with a median of $2.4 million recorded in 2022.
• Year-over-year, Revenue rose 14.47% in 2025 and plunged 98.93% in 2026.
• Over 5 years, Revenue stood at $2.8 million in 2022, then dropped by 19.95% to $2.3 million in 2023, then rose by 11.03% to $2.5 million in 2024, then plunged by 80.83% to $483760.0 in 2025, then slumped by 84.26% to $76156.0 in 2026.
• Per Business Quant data, the three most recent Revenue figures were $76156.0 in Q2 2026, $22842.0 in Q1 2026, and $483760.0 in Q4 2025.